NCT06210672View on ClinicalTrials.gov

Natural History Study in Patients With LGMDR5/2c

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

January 10, 2025

Primary Completion Date

September 1, 2025

Study Completion Date

September 1, 2025

Conditions
Gamma-sarcoglycanopathy
Trial Locations (3)

92380

Hopital Raymond Poincare, Garches

Unknown

Hedi Chaker Hospital Child Neurology Department, Sfax

National Institute Mongi Ben Hmida of Neurology, Tunis

Sponsors
All Listed Sponsors
lead

Atamyo Therapeutics

INDUSTRY

NCT06210672 - Natural History Study in Patients With LGMDR5/2c | Biotech Hunter | Biotech Hunter